Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management.
Zhao EJ, Cheng CV, Mattman A, Chen LYC.
Lancet Haematol. 2021 May;8(5):e365-e375. doi: 10.1016/S2352-3026(21)00056-9.
Hypergammaglobulinaemia and autoimmune rheumatic diseases.
Ehrenstein MR, Isenberg DA.
Ann Rheum Dis. 1992 Nov;51(11):1185-7. doi: 10.1136/ard.51.11.1185.
Polyclonal hypergammaglobulinaemia: towards definition of a threshold.
Baillou C, Jacomet F, Dejoie T, Lureau P, Beuvon C, Grados A, Martins P, Roblot P, Puyade M, Martin M.
Postgrad Med J. 2023 May 22;99(1170):296-301. doi: 10.1136/postgradmedj-2021-140591.
A novel gain-of-function missense variant in PLCG2 associated with autoinflammation and hypergammaglobulinaemia.
Itakura T, Sasaki H, Hosoya T, Yamaguchi T, Mimori E, Saimon Y, Iwai H, Umezawa N, Kawata D, Kimura N, Kurata M, Shimizu M, Yasuda S.
Rheumatology (Oxford). 2023 Nov 2;62(11):e319-e321. doi: 10.1093/rheumatology/kead193.
Hypergammaglobulinaemia and IgG subclass deficiency.
Jeandel C, Gueant JL, Petipain N, Laurain MC, Jouanny MD.
Lancet. 1992 Nov 14;340(8829):1225-6.
Polyclonal hypergammaglobulinaemia with hyperviscosity syndrome.
Paul B.
Br J Haematol. 2002 Sep;118(3):922-3.
Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia.
Angeli-Besson C, Koeppel MC, Jacquet P, Andrac L, Sayag J.
Br J Dermatol. 1994 Mar;130(3):394-7. doi: 10.1111/j.1365-2133.1994.tb02940.x.
[Hypergammaglobulinaemia in cirrhosis (author's transl)].
Fischer D, Paraf A.
Gastroenterol Clin Biol. 1980 Jun-Jul;4(6-7):474-85.
Hyper-IgM syndrome.
Di Santo JP, de Saint Basile G, Durandy A, Fischer A.
Res Immunol. 1994 Mar-Apr;145(3):205-9; discussion 244-9. doi: 10.1016/s0923-2494(94)80185-1.
[IgG4-related disease (IgG4-RD)].
Ebbo M, Schleinitz N.
Ann Pathol. 2012 Nov;32(5 Suppl):S70-1. doi: 10.1016/j.annpat.2012.07.015. Epub 2012 Oct 12.
